APHYX
Price
$24.03
Change
+$0.11 (+0.46%)
Updated
Sep 11 closing price
Net Assets
2.97B
RNWHX
Price
$107.05
Change
-$0.71 (-0.66%)
Updated
Sep 11 closing price
Net Assets
90.01B
Interact to see
Advertisement

APHYX vs RNWHX

APHYX vs RNWHX Comparison Chart in %
View a ticker or compare two or three
VS
APHYX vs. RNWHX commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APHYX is a Hold and RNWHX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNWHX has more cash in the bank: 90B vs. APHYX (2.97B). RNWHX pays higher dividends than APHYX: RNWHX (1.15) vs APHYX (0.00). APHYX was incepted earlier than RNWHX: APHYX (11 years) vs RNWHX (11 years). APHYX (1.05) is less costly to investors than RNWHX (0.72). APHYX is a more actively managed with annual turnover of: 77.88 vs. RNWHX (46.00). RNWHX has a lower initial minimum investment than APHYX: RNWHX (250) vs APHYX (1000000). RNWHX annual gain was more profitable for investors over the last year : 17.19 vs. APHYX (-7.04). RNWHX return over 5 years is better than : 17.68 vs. APHYX (-10.66).
APHYXRNWHXAPHYX / RNWHX
Total Expense Ratio1.050.72146%
Annual Report Gross Expense Ratio1.050.72146%
Fund Existence11 years11 years-
Gain YTD2.69216.44716%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets2.97B90B3%
Annual Yield % from dividends0.001.15-
Returns for 1 year-7.0417.19-41%
Returns for 3 years52.7753.8498%
Returns for 5 years-10.6617.68-60%
Returns for 10 years135.14111.44121%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FLPEX46.310.28
+0.61%
Fidelity Advisor Low-Priced Stock C
FACDX64.25N/A
N/A
Fidelity Advisor Health Care A
EXHAX26.61N/A
N/A
Manning & Napier Pro-Blend Max Term S
LMCFX35.98N/A
N/A
Lord Abbett Mid Cap Stock F
MSAWX22.51N/A
N/A
Morgan Stanley Inst Asia Opp C